Why Novartis Is Buying The Medicines Company For $9.7 Billion

Novartis AG is paying $9.7 billion to buy The Medicines Company. For what? Its medicines, of course. Actually make that medicine singular. Yes, Novartis Chief Executive Officer Vas Narasimhan pulled the trigger on a deal to get one particular type of medicine that’s not quite reached the market yet. It’s name is inclisiran.